A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies. Rhein S, Cakmak-Gorur N, Grunert C, Al-Tabatabaee S, et al. Blood 2026;147:1058-1069.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rhein S, Cakmak-Gorur N, Grunert C, Al-Tabatabaee S, et al. A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies. Blood 2026;147:1058-1069.
PMID: 41100732